Christopher Guttman-McCabe - 25 Aug 2026 Form 4 Insider Report for Anterix Inc. (ATEX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Aug 2026, 16:44:22 UTC
Prior SEC filing
14 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
s/ Gena L. Ashe, Attorney-in-Fact

Key filing fact

Christopher Guttman-McCabe filed Form 4 for Anterix Inc. (ATEX) on 27 Aug 2026.

Key facts

  • This page summarizes Christopher Guttman-McCabe's Form 4 filing for Anterix Inc. (ATEX).
  • 7 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Aug 2026, 16:44.

Change

  • Previous filing in this sequence was filed on 14 Jul 2026.
  • Current net transaction value: -$2,164,837.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001828490 Primary reporting owner

Guttman-McCabe Christopher

Relationship
Chief Reg & Comm Officer
Address
3 GARRET MOUNTAIN PLAZA, SUITE 401, WOODLAND PARK
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Signature date
27 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATEX transaction

Common Stock

Options Exercise

Transaction value
Shares
+40,000
Change %
+89%
Price
$34.72*
Shares after
84,876
Date
25 Aug 2026
Ownership
Direct
ATEX transaction

Common Stock

Tax liability

Transaction value
Shares
-16,561
Change %
-20%
Price
$90.38*
Shares after
68,315
Date
25 Aug 2026
Ownership
Direct
Footnotes
F1
ATEX transaction

Common Stock

Sale

Transaction value
$502,746
Shares
-5,372
Change %
-7.9%
Price
$93.59
Shares after
62,943
Date
25 Aug 2026
Ownership
Direct
Footnotes
F2
ATEX transaction

Common Stock

Sale

Transaction value
$722,764
Shares
-7,791
Change %
-12%
Price
$92.77
Shares after
55,152
Date
25 Aug 2026
Ownership
Direct
Footnotes
F3
ATEX transaction

Common Stock

Sale

Transaction value
$695,044
Shares
-7,580
Change %
-14%
Price
$91.69
Shares after
47,572
Date
25 Aug 2026
Ownership
Direct
Footnotes
F4
ATEX transaction

Common Stock

Sale

Transaction value
$244,283
Shares
-2,696
Change %
-5.7%
Price
$90.61
Shares after
44,876
Date
25 Aug 2026
Ownership
Direct
Footnotes
F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATEX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-40,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
25 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$37.42
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The Reporting Person exercised a stock option to purchase 40,000 shares of the Issuer's Common Stock for $37.42 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 16,561 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.215 to $93.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.265 to $92.265, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.205 to $91.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.01 to $90.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.

Footnote F6

The option shares are fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .